Approval · Notice of Compliance 32282 · 2023
LYDERM: Notice of Compliance 32282
Issued December 6, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32282
- Date
- December 6, 2023
- Company
- Taropharma, A Division Of Taro Pharmaceuticals Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph. Update to Labels to align with Plain Language Labelling (PLL) regulations. Product Name Change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LYDERM | 00716863 | Marketed |
Medicinal ingredients
- FLUOCINONIDE 0.5 MG per G